L710-0321 Screening compound: 4-methyl-1-{5-[2-(piperidine-1-carbonyl)phenyl]-1,3-oxazole-4-carbonyl}piperidine

L710-0321 Screening compound: 4-methyl-1-{5-[2-(piperidine-1-carbonyl)phenyl]-1,3-oxazole-4-carbonyl}piperidine
L710-0321 Screening compound: 4-methyl-1-{5-[2-(piperidine-1-carbonyl)phenyl]-1,3-oxazole-4-carbonyl}piperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound L710-0321
4-methyl-1-{5-[2-(piperidine-1-carbonyl)phenyl]-1,3-oxazole-4-carbonyl}piperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L710-0321

Molecular Formula

C22H27N3O3 (C22 H27 N3 O3)

Compound Name

4-methyl-1-{5-[2-(piperidine-1-carbonyl)phenyl]-1,3-oxazole-4-carbonyl}piperidine

IUPAC name

4-methyl-1-{5-[2-(piperidine-1-carbonyl)phenyl]-13-oxazole-4-carbonyl}piperidine

SMILES

CC(CC1)CCN1C(c1c(-c(cccc2)c2C(N2CCCCC2)=O)ocn1)=O

InChI

InChI=1S/C22H27N3O3/c1-16-9-13-25(14-10-16)22(27)19-20(28-15-23-19)17-7-3-4-8-18(17)21(26)24-11-5-2-6-12-24/h3-4,7-8,15-16H,2,5-6,9-14H2,1H3

InChI Key

ZMIPDJQVPHJXER-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27472499

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

381.47

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.834

Distribution Coefficient, logD

2.834

Water Solubility, LogSw

-3.29

Polar Surface Area

52.371

Acid Dissociation Constant (pKa)

26.31

Base Dissociation Constant (pKb)

-2.79

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

L710-0321 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Receptor-type Protein Tyrosine Phosphatases Library (3746 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Therapeutical areas:
  • Cancer
  • Digestive system
  • Nervous system
  • Female
  • Metabolic
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with L710-0321 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L710-0321?
Check Price and Availability of L710-0321, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L710-0321 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L710-0321
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L710-0321
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L710-0321 available by request